Manufacturer record
Aarti Drugs Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Aarti Drugs Limited (Maharashtra) were declared Not of Standard Quality in January 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: NFC/18121100, Norfloxacin IP (exp Nov 2023). CDTL Mumbai (CDSCO lab) found it not of standard quality: Loss on Drying. Listed in the January 2019 alert.
Records by type
3 records linked to Aarti Drugs Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Norfloxacin IP | Batch NFC/18121100Mfg Dec 2018 · Exp Nov 2023 | Loss on DryingLoss on drying | CDTL MumbaiCDSCO lab | Jan 2019 |
| Norfloxacin IP | Batch NFC/18121099Mfg Dec 2018 · Exp Nov 2023 | Loss on DryingLoss on drying | CDTL MumbaiCDSCO lab | Jan 2019 |
| Norfloxacin IP | Batch NFC/18121098Mfg Dec 2018 · Exp Nov 2023 | Loss on DryingLoss on drying | CDTL MumbaiCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.